{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:57:05Z","timestamp":1791619025115,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.diabres.2008.09.028","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T05:06:20Z","timestamp":1224133580000},"page":"S59-S62","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S1","title":["Role of TSC\u2013mTOR pathway in diabetic nephropathy"],"prefix":"10.1016","volume":"82","author":[{"given":"Ken","family":"Inoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2008.09.028_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"Tor signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2008.09.028_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the tsc-mtor pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.diabres.2008.09.028_bib3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb gtpase is a direct target of tsc2 gap activity and regulates mtor signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.diabres.2008.09.028_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"Tsc2 is phosphorylated and inhibited by akt and suppresses mtor signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.diabres.2008.09.028_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2008.09.028_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","article-title":"Amp-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism","volume":"1","author":"Kahn","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.diabres.2008.09.028_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"Tsc2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2008.09.028_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The tsc1-2 tumor suppressor controls insulin-pi3k signaling via regulation of irs proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.diabres.2008.09.028_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of s6k1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2008.09.028_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1523-1755.2005.00433.x","article-title":"Gas6 induces akt\/mtor-mediated mesangial hypertrophy in diabetic nephropathy","volume":"68","author":"Nagai","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2008.09.028_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1681\/ASN.2005050549","article-title":"Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats","volume":"17","author":"Lloberas","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.028_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000106782","article-title":"Rapamycin prevents early steps of the development of diabetic nephropathy in rats","volume":"27","author":"Yang","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.028_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2353\/ajpath.2007.070412","article-title":"Regulation of elongation phase of mrna translation in diabetic nephropathy: amelioration by rapamycin","volume":"171","author":"Sataranatarajan","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.diabres.2008.09.028_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbrc.2005.12.012","article-title":"Inhibition of mtor signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice","volume":"340","author":"Sakaguchi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.diabres.2008.09.028_bib15","doi-asserted-by":"crossref","first-page":"F617","DOI":"10.1152\/ajprenal.00278.2006","article-title":"A role for amp-activated protein kinase in diabetes-induced renal hypertrophy","volume":"292","author":"Lee","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.diabres.2008.09.028_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"Tsc2 regulates vegf through mtor-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.diabres.2008.09.028_bib17","first-page":"5645","article-title":"Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors","volume":"62","author":"Kenerson","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.diabres.2008.09.028_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(05)78974-1","article-title":"Angiotensin ii, vegf, and diabetic retinopathy","volume":"351","author":"Williams","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2008.09.028_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1523-1755.1998.00829.x","article-title":"Glomerular expression of p27kip1 in diabetic db\/db mouse: role of hyperglycemia","volume":"53","author":"Wolf","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2008.09.028_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.ASN.0000051726.41601.C0","article-title":"The lack of cyclin kinase inhibitor p27(kip1) ameliorates progression of diabetic nephropathy","volume":"14","author":"Awazu","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.028_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V125993","article-title":"Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes","volume":"12","author":"de Vriese","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.diabres.2008.09.028_bib22","doi-asserted-by":"crossref","first-page":"H1232","DOI":"10.1152\/ajpheart.00040.2004","article-title":"Ang ii activates effectors of mtor via pi3-k signaling in human coronary smooth muscle cells","volume":"287","author":"Hafizi","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.diabres.2008.09.028_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cellsig.2007.10.027","article-title":"Raptor\u2013rictor axis in tgfbeta-induced protein synthesis","volume":"20","author":"Das","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.diabres.2008.09.028_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200611146","article-title":"Cell size and invasion in tgf-beta-induced epithelial to mesenchymal transition is regulated by activation of the mtor pathway","volume":"178","author":"Lamouille","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.diabres.2008.09.028_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mtorc2 assembly and akt\/pkb","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell."},{"key":"10.1016\/j.diabres.2008.09.028_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mtorc components raptor, rictor, or mlst8 reveals that mtorc2 is required for signaling to akt-foxo and pkcalpha, but not s6k1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.diabres.2008.09.028_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of akt\/pkb by the rictor\u2013mtor complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.diabres.2008.09.028_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","article-title":"Protein kinase c activation and the development of diabetic complications","volume":"47","author":"Koya","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2008.09.028_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(98)01346-4","article-title":"Pathogenesis, prevention, and treatment of diabetic nephropathy","volume":"352","author":"Cooper","year":"1998","journal-title":"Lancet"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708004427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822708004427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T17:40:03Z","timestamp":1631986803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822708004427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":29,"alternative-id":["S0168822708004427"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2008.09.028","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}